tiprankstipranks
Trending News
More News >
Houlihan Lokey (HLI)
NYSE:HLI

Houlihan Lokey (HLI) AI Stock Analysis

Compare
195 Followers

Top Page

HLI

Houlihan Lokey

(NYSE:HLI)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
,
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
$149.00
â–²(7.23% Upside)
Action:DowngradedDate:02/04/26
The score is driven primarily by solid underlying financial performance and a constructive earnings-call outlook (growth, improving deal visibility, strong liquidity/capital deployment). These positives are tempered by notably weak technical momentum (below major moving averages with negative MACD) and a relatively premium valuation with only a modest dividend yield.
Positive Factors
Strong profitability & ROE
Sustained high margins and ~20% ROE indicate durable fee pricing power and efficient capital use. This profit base supports reinvestment, hiring and returns to shareholders, and provides a buffer through cycles, underpinning long-term cash generation and strategic flexibility.
Healthy liquidity and capital flexibility
A ~$1.2B cash position and active, prioritized capital deployment (acquisitions then buybacks) gives durable optionality to pursue strategic tuck-ins, invest in talent and weather downturns without urgent financing, strengthening long-term growth and resilience.
Leading market position & European expansion
Top global rankings and targeted European acquisitions expand cross-border advisory capabilities and sponsor relationships, deepening market share and fee pipeline. This durable franchise advantage supports repeat business and scalability in higher-margin advisory services.
Negative Factors
Rising leverage
Debt-to-equity roughly doubled year-over-year, signaling greater financial leverage. While still moderate, higher debt raises interest and refinancing risk, constrains flexibility for large bolt-on M&A or buybacks in tighter markets, and increases sensitivity to cash-flow variability.
Revenue cyclicality & restructuring risk
Restructuring is countercyclical and corporate finance remains deal-driven; as markets normalize restructuring demand may decline and M&A visibility can fluctuate. This structural cyclicality produces uneven revenue and margin trajectories, complicating medium-term forecasting and staffing.
Rising compensation and integration costs
Absolute compensation and non-comp expense growth, plus acquisition-related integration costs, press operating leverage. If new hires or acquisitions don't scale revenue quickly, elevated expense baselines could compress margins and reduce the durability of current profitability.

Houlihan Lokey (HLI) vs. SPDR S&P 500 ETF (SPY)

Houlihan Lokey Business Overview & Revenue Model

Company DescriptionHoulihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.
How the Company Makes MoneyHoulihan Lokey primarily makes money by earning fees for advisory services, with revenue largely driven by successfully completed client engagements and, in many cases, transaction outcomes. 1) Corporate Finance (transaction advisory fees) - M&A advisory fees: The firm earns success-based fees when it advises on the sale, purchase, merger, or divestiture of a business. These fees are typically contingent on deal completion and are often larger than upfront retainers. - Capital markets / financing advisory: The firm earns fees for advising clients on raising capital (debt and/or equity) or refinancing, including placement/structuring advisory. Fees may include retainers plus completion-based components tied to the closing of a financing. - Financial sponsor coverage: Advising private equity and other sponsors on acquisitions, exits, and financings generates similar transaction-driven fees. 2) Financial Restructuring (restructuring and liability management fees) - Restructuring advisory: The firm earns fees for advising companies, creditor groups, and other parties on out-of-court restructurings, liability management transactions, and in-court processes such as Chapter 11. Engagements often include monthly retainers and additional fees tied to milestones, court-approved fee processes (in certain bankruptcy cases), and/or success-based outcomes. - Countercyclical demand: This segment can contribute meaningfully during periods of market stress when defaults rise and clients seek balance-sheet restructuring. 3) Financial and Valuation Advisory (valuation and opinions fees) - Valuation services: The firm earns project-based fees for valuing businesses, securities, illiquid assets, and complex instruments for purposes such as financial reporting, tax, fairness considerations, and transactions. - Opinions and advisory reports: The firm earns fees for fairness opinions, solvency opinions, and other advisory analyses often required in M&A, financing, and restructuring contexts. - These revenues are generally more recurring/engagement-based than pure transaction success fees, though volumes can still be influenced by broader market activity. Additional factors influencing earnings - Deal volume and market conditions: Corporate Finance revenue tends to be sensitive to M&A and financing activity levels, while Restructuring can be stronger in downturns. - Fee mix (retainers vs. success fees): A portion of revenue may come from retainers and ongoing advisory work, but a meaningful share is typically realized upon successful completion of transactions or restructuring outcomes. - Client relationships and repeat business: Revenue is supported by repeat engagements with corporates, financial sponsors, and creditor constituencies. Significant partnerships or specific revenue-sharing arrangements: null

Houlihan Lokey Earnings Call Summary

Earnings Call Date:Jan 28, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call delivered multiple clear positive operating and strategic signals: double-digit revenue and EPS growth, strong performance across core businesses (notably Corporate Finance and Restructuring this quarter), an expanding European presence via targeted acquisitions, a healthy balance sheet (~$1.2B cash), and top-market industry rankings. Offsetting items are manageable: rising absolute compensation and non-comp costs (though ratios are stable), localized cost pressure from acquisitions, and caution about restructuring revenue as markets improve plus macro/geopolitical uncertainty. Overall, the positives — revenue/earnings growth, deal pipeline strength, strategic M&A and market share momentum — outweigh the cautions.
Q3-2026 Updates
Positive Updates
Strong Quarter — Revenue and EPS Growth
Total revenues of $717 million, up 13% year-over-year; adjusted EPS of $1.94, up 18% year-over-year.
Corporate Finance Momentum
Corporate Finance revenue of $474 million, up 12% year-over-year; closed 177 transactions vs. 170 a year ago; average transaction fee increased and new-business activity trending upward, supporting optimism for fiscal 2027.
Financial Restructuring Outperformed Seasonality
Restructuring revenue of $156 million, up 19% year-over-year; closed 41 transactions (flat YoY) with higher average fees; several deals accelerated into Q3, producing a stronger-than-typical Q3 and reversing the usual seasonal pattern.
Financial & Valuation Advisory Growth
Revenue of $87 million, up 6% year-over-year; 1,103 fee events vs. 1,015 a year ago (10% increase), with solid new business heading into Q4.
Strategic M&A and European Expansion
Completed acquisition of Mellon Capital's real estate advisory business and announced agreement for a controlling interest in O'Dare Partners (France) to increase European footprint (expected to own 51% at close); hired 6 new managing directors in Q3 and added 11 colleagues in Munich and London.
Balance Sheet Strength and Capital Deployment
Ended quarter with ~ $1.2 billion cash and investments; repurchased ~418,000 shares in Q3; management emphasizes flexibility to deploy cash for strategic acquisitions while continuing measured buybacks.
Industry Recognition and Talent Investment
Named the #1 most active M&A investment bank and #1 most active financial restructuring investment bank globally for 2025; continued hiring and investments across geographies and products (6 MDs hired in Q3).
Improved Tax Efficiency
Adjusted effective tax rate of 30.6% in the quarter versus 33.3% a year ago, driven by decreased state taxes and decreased non-deductible expenses.
Negative Updates
Restructuring Outlook Uncertainty for FY2027
Management expects potential revenue pressures in Financial Restructuring as markets improve (structural decline in demand for restructuring when M&A and capital availability improve), creating uncertainty about near-term restructuring revenue levels despite Q3 strength.
Expense Growth — Compensation and Non-Comp
Adjusted compensation expense rose to $441 million from $390 million YoY; adjusted compensation expense ratio held at 61.5% but absolute compensation increased. Adjusted non-compensation expenses are up 11% year-to-date and the company expects Q4 non-comp growth to be consistent with YTD levels.
Localized Cost Pressure from Acquisitions
Elevated rent and related non-comp costs in Europe tied to recent acquisitions noted; Q3 included $2.2 million integration/acquisition costs and other acquisition-related adjustments.
Market & Macro Uncertainties
Geopolitical events and concerns in private credit markets were cited as variables that could both suppress and unpredictably increase restructuring activity; management flagged these as contributors to uneven visibility.
Q4 Seasonality and Timing Risk
Because several restructuring transactions accelerated into Q3, management expects Q4 to more closely resemble Q1–Q2 and not show the typical seasonal strength, introducing timing risk for quarter-to-quarter comparisons.
Company Guidance
The company guided to continued momentum into fiscal 2027 driven by improving M&A activity and stronger visibility into deal activity/backlog, reporting Q3 revenues of $717 million and adjusted EPS of $1.94 (up 13% and 18% YoY, respectively), with Corporate Finance at $474M (up 12%, 177 closed deals vs. 170), Financial Restructuring $156M (up 19%, 41 deals), and Financial & Valuation Advisory $87M (up 6%, 1,103 fee events vs. 1,015, +10%); they noted Q3 restructuring strength may reverse typical seasonality (Q3 > Q4) but expect restructuring revenues to face pressure in FY27 (though geopolitical risks could increase activity). On costs, adjusted compensation was $441M vs. $390M (adjusted comp ratio 61.5%, target maintained), adjusted non-comp ratio 13.1% (YTD non-comp expenses +11%) with $2.2M, $1.3M and $0.6M of specific adjustments; adjusted tax rate 30.6% (vs. 33.3%). Balance sheet/capital deployment metrics: cash & investments ≈ $1.2B, ~418,000 shares repurchased in Q3, preference to prioritize strategic acquisitions (pipeline described as strong) then dividends/repurchases.

Houlihan Lokey Financial Statement Overview

Summary
Solid profitability (TTM net margin ~17%, EBIT margin ~23%) and strong ROE (~20%) support a high-quality profile. Offsets include uneven, cyclical revenue history, a notable increase in leverage (debt-to-equity ~0.43 vs. ~0.20 prior period), and some variability in cash-flow conversion with slightly negative TTM free-cash-flow growth.
Income Statement
78
Positive
HLI shows solid profitability with TTM (Trailing-Twelve-Months) net margin around 17% and healthy operating profitability (EBIT margin ~23%). Revenue has re-accelerated in TTM (Trailing-Twelve-Months) with strong growth versus the most recent annual period, and margins have generally improved from 2023–2024 levels. The main offset is cyclicality: revenue growth has been uneven over the last several years (including a down year in 2023), and margins remain below the peak levels seen in 2021–2022.
Balance Sheet
74
Positive
The balance sheet looks sound with moderate leverage and strong profitability on equity. TTM (Trailing-Twelve-Months) debt-to-equity is ~0.43, higher than the prior annual period (~0.20), indicating increased reliance on debt, but still not excessive for the business. Equity has grown over time and return on equity remains strong (about 20% TTM (Trailing-Twelve-Months)), though below the very high levels achieved in 2022.
Cash Flow
71
Positive
Cash generation is strong with TTM (Trailing-Twelve-Months) free cash flow close to net income (free cash flow to net income ~0.96), suggesting earnings quality is solid. However, free cash flow growth is slightly negative in TTM (Trailing-Twelve-Months), and cash conversion has been somewhat variable across years (notably weaker operating cash flow relative to earnings in 2023–2024), which reduces confidence in consistency.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.65B2.39B1.91B1.81B2.27B1.53B
Gross Profit1.43B919.92M737.05M696.64M861.32M554.26M
EBITDA667.85M597.59M427.63M435.03M661.40M423.38M
Net Income447.78M399.71M280.30M254.22M437.75M312.77M
Balance Sheet
Total Assets3.94B3.82B3.17B2.97B2.89B2.43B
Cash, Cash Equivalents and Short-Term Investments1.18B1.14B728.80M720.69M833.70M846.85M
Total Debt994.26M438.19M415.41M374.87M197.63M175.33M
Total Liabilities1.64B1.64B1.33B1.36B1.44B1.04B
Stockholders Equity2.29B2.17B1.84B1.61B1.44B1.38B
Cash Flow
Free Cash Flow738.94M808.91M261.73M85.54M727.92M565.69M
Operating Cash Flow769.48M848.61M328.46M136.27M736.60M579.84M
Investing Cash Flow-54.57M-265.06M-70.41M-3.00M-273.91M-99.75M
Financing Cash Flow-491.25M-329.07M-250.59M-240.46M-459.06M-26.82M

Houlihan Lokey Technical Analysis

Technical Analysis Sentiment
Negative
Last Price138.95
Price Trends
50DMA
166.84
Negative
100DMA
172.88
Negative
200DMA
181.55
Negative
Market Momentum
MACD
-8.30
Positive
RSI
20.93
Positive
STOCH
8.66
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLI, the sentiment is Negative. The current price of 138.95 is below the 20-day moving average (MA) of 153.17, below the 50-day MA of 166.84, and below the 200-day MA of 181.55, indicating a bearish trend. The MACD of -8.30 indicates Positive momentum. The RSI at 20.93 is Positive, neither overbought nor oversold. The STOCH value of 8.66 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HLI.

Houlihan Lokey Risk Analysis

Houlihan Lokey disclosed 27 risk factors in its most recent earnings report. Houlihan Lokey reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Houlihan Lokey Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$5.27B20.1121.69%1.63%12.77%36.43%
71
Outperform
$4.31B22.1344.30%3.69%51.19%456.59%
70
Outperform
$10.89B16.1433.81%0.95%27.00%63.47%
69
Neutral
$10.88B12.5511.96%1.43%7.54%2.73%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
64
Neutral
$9.70B24.9020.14%1.33%20.99%25.02%
56
Neutral
$7.89B17.256.84%2.52%-5.41%25.28%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLI
Houlihan Lokey
138.95
-21.14
-13.20%
EVR
Evercore Partners
274.89
72.85
36.06%
JEF
Jefferies
38.21
-19.28
-33.54%
PIPR
Piper Sandler
295.61
44.98
17.95%
SF
Stifel Financial
70.31
5.95
9.25%
MC
Moelis
53.96
-4.07
-7.02%

Houlihan Lokey Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance
Houlihan Lokey Files Prospectus Supplement for Share Resales
Neutral
Feb 25, 2026

On February 25, 2026, Houlihan Lokey filed a prospectus supplement with the SEC covering the potential resale of up to 4,009 Class A shares issuable upon conversion of Class B shares previously granted to former members of Waller Helms Advisors after they met post-closing performance targets on January 20, 2026. The filing also covers the possible resale of some or all of 28,412 Class A shares issuable upon conversion of Class B shares held by former owners of 7 Mile Advisors, issued following the December 2023 acquisition and subsequent attainment of performance milestones in December 2025 and January 2026, clarifying the legal status of these shares without itself constituting an offer to sell the securities.

The most recent analyst rating on (HLI) stock is a Hold with a $176.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.

Executive/Board Changes
Houlihan Lokey announces planned director board departure
Neutral
Jan 29, 2026

On January 24, 2026, Houlihan Lokey, Inc. announced that director Robert A. Schriesheim, who has served on the company’s board since July 2015, notified the firm that he will not stand for reelection when his current term ends at the 2027 Annual Meeting of Shareholders. His planned departure signals an upcoming change in the company’s board composition in 2027, which may open the door for new leadership perspectives and governance adjustments as the firm prepares for its next phase of strategic oversight.

The most recent analyst rating on (HLI) stock is a Buy with a $201.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Houlihan Lokey Amends and Restates Class B Voting Trust
Neutral
Dec 30, 2025

On December 30, 2025, Houlihan Lokey, Inc. entered into an amended and restated voting trust agreement that replaces its prior 2015 voting trust structure governing Class B common stock. The revised agreement updates termination triggers, including ending the trust 10 years after the date on which all Class B shares convert into Class A or once the trust’s holdings fall below 5% of outstanding common stock, and introduces a requirement that any trust-held stake above 30% of the company’s outstanding shares after that conversion be voted proportionally with other shareholders. It also broadens employee flexibility by allowing former employees (no longer employed for at least 12 months) to have their shares released from the trust after the final conversion date and by expanding circumstances under which employees can withdraw shares for certain pledging, hedging, monetization, or similar transactions, subject to the company’s insider trading policy. Because some directors serve as trustees and hold Class B shares subject to the trust, a special committee of disinterested directors was formed to review and negotiate the new agreement, and, after consulting independent advisors and management, the committee unanimously approved the amended and restated voting trust agreement and authorized officers to execute it, clarifying governance and voting mechanics for major shareholders and employees.

The most recent analyst rating on (HLI) stock is a Buy with a $228.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 04, 2026